Innovia Medical Advances Strategic Vision with Acquisitions of Grace Medical and Hurricane Medical
ST. PAUL, Minn. — Innovia Medical, a global medical device company focused on specialty surgical products, announced today the acquisitions of two well-respected specialty medical device companies: Grace Medical, a global leader in Ear, Nose, and Throat (ENT) solutions, and Hurricane Medical, a trusted provider of Ophthalmic surgical products.
Article content
These acquisitions mark a pivotal milestone in Innovia Medical's continued growth, reinforcing its commitment to building a globally integrated platform of specialty surgical solutions. By uniting distinct areas of expertise and synergistic product portfolios, Innovia Medical is expanding its clinical reach and strengthening its ability to support healthcare providers and patients worldwide.
Article content
Article content
'Grace Medical and Hurricane Medical have each built strong reputations within ENT and Ophthalmology, and we are proud to bring their expertise and talent into the Innovia Medical family,' said Terry Meredith, CEO of Innovia Medical. 'Grace Medical brings a leading portfolio of highly specialized ENT products that address complex surgical needs, while Hurricane Medical adds a complementary range of Ophthalmic solutions, backed by strong manufacturing capabilities and a deep commitment to customer service. Together, these additions strengthen our ability to deliver comprehensive, high-quality solutions that empower clinicians, improve patient care, and advance our vision for specialty surgical innovation.'
Article content
Grace Medical, headquartered in Memphis, TN, brings a strong portfolio of advanced ENT technologies and a legacy of clinical leadership. 'We look forward to expanding our ENT presence with Innovia Medical and continuing to service ENT customers around the world,' said Murray Beard, CEO of Grace Medical. Michael Crook, President, Chief Operating Officer of Grace Medical, will lead the strategic direction of the ENT division at Innovia Medical. Reflecting on the partnership, he shared: 'Joining forces with Innovia Medical brings together two highly complementary organizations – creating a world-class ENT platform with the scale, expertise, and product depth needed to better serve specialists and advance patient care.'
Article content
Hurricane Medical, based in Bradenton, FL, is a respected provider of high-quality Ophthalmic surgical solutions. 'We see a tremendous opportunity to grow Hurricane Medical's product coverage through Innovia Medical's commercial reach and global infrastructure,' said Dell Bauslaugh, President of Hurricane Medical. 'We are excited for what this means for our customers and our team.'
Article content
Customers and partners can expect continuity in operations, with the same sales and service contacts remaining in place. The integration of these organizations is expected to result in enhanced capabilities, increased resources, broader product portfolios, and a shared commitment to delivering outstanding outcomes for patients and clinicians alike.
Article content
Innovia Medical and its long-term growth strategy are backed by private investment firm Inverness Graham Investments.
Article content
About Innovia Medical
Article content
Article content
Article content
Contacts
Article content
Media Contact:
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
30 minutes ago
- CTV News
U.S. stocks tick higher and yields leap as Wall Street sees little chance for a July rate cut
Trader Jason Hardzewicz works on the floor of the New York Stock Exchange, Tuesday, July 1, 2025. (AP Photo/Richard Drew) NEW YORK — U.S. stocks are ticking further into record heights after a report showed the U.S. job market looks stronger than Wall Street expected. The S&P 500 rose 0.3% Thursday and was on track to set an all-time high for the fourth time in five days. The Dow Jones Industrial Average added 88 points, and the Nasdaq composite gained 0.5%. The reaction was bigger in the bond market, where Treasury yields jumped. The strong data on U.S. jobs pushed traders to erase bets that the Federal Reserve could cut its main interest rate at its next meeting later this month. By Teresa Cerojano and Matt Ott
Globe and Mail
33 minutes ago
- Globe and Mail
Strategy (MSTR) Is Interesting, but MSTY Is Better
During the past five years, Strategy (NASDAQ: MSTR) has been one of the top-performing stocks in the world. It's up a head-spinning 3,200% during that period. And it shows no signs of letting up anytime soon. Year to date, Strategy (formerly known as MicroStrategy) is up 32%. But here's the thing: If you want regular cash flow and a steady stream of high monthly income, those capital gains aren't going to help you. You will only generate income if you sell the stock. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » As an alternative, you could invest in the YieldMax MSTR Option Income Strategy ETF (NYSEMKT: MSTY). This exchange-traded fund (ETF) generates monthly income for investors using options tied to Strategy stock. There's a lot to unpack, so let's take a closer look. What is MSTY? The YieldMax MSTR Option Income Strategy ETF is an investment product that offers extreme exposure to Strategy stock. You can think of it as a "1-stock ETF," except that you don't actually own the underlying stock in the ETF. Instead, the ETF generates income by selling (i.e., "writing") call options on Strategy stock. This income for the investor is measured in terms of distribution rate. This refers to the income generated by the ETF as a percentage of its net asset value. The higher the distribution rate, the more money you receive. Right now, the distribution rate of MSTY is 93%. That's much higher than the distribution rates of other popular YieldMax ETFs. For example, the distribution rate of the YieldMax ETF for Tesla stock is 59%. The distribution rate of the YieldMax ETF for Apple stock is 32%. This high distribution rate is the result of a nifty feat of financial alchemy that uses derivatives (i.e., options) to transform a non-yield-bearing asset (MSTR stock) into a yield-bearing asset (the MSTY ETF). In short, you're able to generate a yield from Strategy stock, even though it pays no dividends to investors. That's Wall Street magic. What are the trade-offs involved? As you might have guessed by now, there are some trade-offs involved. After all, on Wall Street, there is no such thing as a free lunch. So, in exchange for giving up some of the high upside potential of MSTR stock, you get a steady monthly income. The strategy is designed to work best when the price of MSTR is not expected to soar dramatically in value. This is very important to keep in mind, since Strategy is highly leveraged to the price of Bitcoin. If the price of Bitcoin surges in value dramatically, then you could be losing out on some of the potential upside of holding MSTR stock. Yes, you will still be generating income and earning a regular yield via the ETF, but it might leave you feeling a bit disappointed, since you do not own shares in the company. On the other hand, if the price of MSTR does not surge in value or falls only slightly, you should come out ahead, because people will still be buying call options on that stock. Thus, you will still be earning income. As YieldMax advises potential investors, this ETF product is best for those who are neutral to moderately bullish on Strategy, and who want monthly income and regular cash flow. It should be used for diversification purposes, and should not compromise a significant portion of your overall portfolio. Caveats about options Before investing in the YieldMax MSTR Option Income Strategy ETF, I would highly advise becoming familiar with call options, just to understand how they behave under different scenarios. At the very least, you should familiarize yourself with basic option payout charts. This YieldMax ETF employs a covered call strategy, meaning any call option is written against a stock that is already owned. Technically, this YieldMax ETF employs a "synthetic" covered call strategy, since it uses a combination of different options to simulate a covered call position, without actually owning the underlying stock. As an investor, all of this happens behind the scenes, and you don't need to know anything about options for the strategy to work. So, even though this might sound incredibly complex, YieldMax does all the heavy lifting for you. At the end of the day, if you're hunting for some extra monthly income and are excited about generating some yield from an investment that normally does not offer any, then the YieldMax MSTR Option Income Strategy ETF could be worth a closer look. Should you invest $1,000 in Tidal Trust II - YieldMax Mstr Option Income Strategy ETF right now? Before you buy stock in Tidal Trust II - YieldMax Mstr Option Income Strategy ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Tidal Trust II - YieldMax Mstr Option Income Strategy ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $697,627!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $939,655!* Now, it's worth noting Stock Advisor 's total average return is1,045% — a market-crushing outperformance compared to178%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 30, 2025
Globe and Mail
39 minutes ago
- Globe and Mail
Buy These 4 Stocks With Solid Sales Growth Amid Market Uncertainty
Markets began 2025 on a strong note but have since been gripped by heightened volatility due to the Trump administration's tariff plans and geopolitical headwinds, which have resulted in uncertainty. The ambiguity has clouded expectations around the tariffs' potential impact on the U.S. economy and the Federal Reserve's policy decisions. Hence, investors are approaching the markets with increased caution. So, the conventional method of selecting stocks is the need of the hour. One such way is choosing stocks with steady sales growth. In this regard, The Walt Disney Company DIS, Agnico Eagle Mines Limited AEM, Adobe Inc. ADBE and Xylem Inc. XYL are worth considering. When evaluating a company, investors often prioritize revenue over earnings, as growing sales indicate an expanding customer base and long-term potential. In contrast, stagnant or declining revenue can signal deeper operational challenges. While short-term profits can be achieved through cost-cutting, sustained earnings growth typically depends on consistent top-line expansion. However, revenue growth alone doesn't paint a complete picture of financial health. A more effective investment strategy involves analyzing a company's cash position alongside its sales. Strong cash reserves and healthy cash flow offer the flexibility to navigate challenges, invest in growth opportunities and maintain operational stability. Selecting the Potential Winning Stocks To shortlist stocks with impressive sales growth and a high cash balance, we have selected 5-Year Historical Sales Growth (%) greater than X-Industry and Cash Flow of more than $500 million as our main screening parameters. But sales growth and cash strength are not the absolute criteria for selecting stocks. Hence, we have added other factors to arrive at a winning strategy. P/S Ratio less than X-Industry: This metric determines the value placed on each dollar of a company's revenues. The lower the ratio, the better it is for picking a stock since the investor is paying less for each unit of sales. % Change F1 Sales Estimate Revisions (four weeks) greater than X-Industry: Estimate revisions, better than the industry, are often seen to trigger an increase in stock price. Operating Margin (average last five years) greater than 5%: Operating margin measures how much every dollar of a company's sales translates into profits. A high ratio indicates that the company has good cost control and sales are increasing faster than costs — an optimal situation. Return on Equity (ROE) greater than 5%: This metric will ensure that sales growth is translated into profits and the company is not hoarding cash. A high ROE means that the company is spending wisely and is in all likelihood profitable. Zacks Rank less than or equal to 2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform, irrespective of the market environment. You can see the complete list of today's Zacks #1 Rank stocks here. 4 Stocks With Robust Sales Growth to Bet on Burbank, CA-based Disney has assets that span movies, television shows and theme parks. DIS operates through three segments: Entertainment, Sports and Experiences. Disney's expected sales growth rate for 2025 is 4.1%. DIS carries a Zacks Rank #2 at present. Agnico Eagle Mines, headquartered in Canada, is a gold producer. AEM has mining operations in Canada, Mexico and Finland, and exploration activities in Canada, Europe, Latin America and the United States. Agnico Eagle Mines' expected sales growth rate for 2025 is 24.6%. AEM currently sports a Zacks Rank #1. Adobe, based in San Jose, CA, is a leading technology company. ADBE provides a personalized digital experience by integrating artificial intelligence (AI) into its solutions. Adobe's sales are expected to rise 9.5% in fiscal 2025. INTU carries a Zacks Rank #2 at present. Washington, D.C.-based Xylem is one of the leading providers of water solutions worldwide. XYL is involved in the full water-process cycle, including collection, distribution and returning of water to the environment. Xylem's expected sales growth for 2025 is 2.2%. XYL, at present, carries a Zacks Rank #2. Get the remaining stock on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial of the Research Wizard today. Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. Disclosure: Performance information for Zacks' portfolios and strategies are available at: 5 Stocks Set to Double Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%. Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. Today, See These 5 Potential Home Runs >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Adobe Inc. (ADBE): Free Stock Analysis Report Agnico Eagle Mines Limited (AEM): Free Stock Analysis Report Xylem Inc. (XYL): Free Stock Analysis Report
